Mirador Therapeutics, Inc.
Clinical trials sponsored by Mirador Therapeutics, Inc., explained in plain language.
-
New drug MT-701 passes early safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called MT-701 in 46 healthy adults aged 19 to 55. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat any disease, …
Phase: PHASE1 • Sponsor: Mirador Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 17, 2026 07:30 UTC
-
New drug MT-501 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new oral drug called MT-501 in 72 healthy adults aged 19 to 55. Participants received either single or multiple doses of the drug or a placebo. The goal was to check for side effects and how the drug moves through the…
Phase: PHASE1 • Sponsor: Mirador Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC